SHA:603233 Revenue

DaShenLin Pharmaceutical Group had revenue of 6.39B CNY in the quarter ending September 30, 2024, with 11.42% growth. This brings the company's revenue in the last twelve months to 26.54B, up 9.88% year-over-year. In the year 2023, DaShenLin Pharmaceutical Group had annual revenue of 24.53B with 15.45% growth.

Revenue (ttm)

26.54B

Revenue Growth

+9.88%

P/S Ratio

0.66

Revenue / Employee

583.72K

Employees

45,466

Market Cap

17.55B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	24.53B	3.28B	15.45%
Dec 31, 2022	21.25B	4.49B	26.78%
Dec 31, 2021	16.76B	2.18B	14.92%
Dec 31, 2020	14.58B	3.44B	30.89%
Dec 31, 2019	11.14B	2.28B	25.76%
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro
Dec 31, 2014	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Shenzhen Mindray Bio-Medical Electronics	37.11B
Jiangsu Hengrui Medicine	26.00B
WuXi AppTec	38.50B
Aier Eye Hospital Group	20.62B
Zhangzhou Pientzehuang Pharmaceutical.,	10.91B
Shanghai United Imaging Healthcare	10.30B
Yunnan Baiyao Group Co.,Ltd	39.34B
Sichuan Biokin Pharmaceutical	5.82B

Revenue Rankings